-Parties: The plaintiffs included AstraZeneca Canada Inc. et al. The defendant was Zydus Lifesciences Limited.

-Subject Matter: This is a Federal Court action under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations), filed on December 29, 2025, and designated as a specially managed proceeding. The matter involves pharmaceutical patent litigation and is being heard in Toronto before Associate Judge Michael D. Crinson as case management judge, with two other related ongoing proceedings (T-3096-25 and T-3922-25). The case is ongoing.

-Date: The hearing was set on June 11, 2026.

-Venue: This was a federal case before the Federal Court.

-Amount: No financial award was specified.